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Safflower (Carthamus tinctorius L.) is a traditional medicinal and edible herb with a long
history of use in China. In this study, a model of hepatotoxicity induced by carbon tetra-
chloride (CCl4) in mice was used to investigate the hepatoprotective effects of kaempferol
3-O-rutinoside (K-3-R) and kaempferol 3-O-glucoside (K-3-G), two kaempferol glycosides
isolated from C. tinctorius L. K-3-R and K-3-G, at doses of 200 mg/kg and 400 mg/kg, were
given orally to male mice once/d for 7 days before they received CCl4 intraperitoneally. Our
results showed that K-3-R and K-3-G treatment increased the level of total protein (TP) and
prevented the CCl4-induced increases in serum aspartate aminotransferase (AST), serum
alkaline phosphatase (ALP), and hepatic malondialdehyde (MDA) levels. Additionally, mice
treated with K-3-R and K-3-G had significantly restored glutathione (GSH) levels and
showed normal catalase (CAT) and superoxide dismutase (SOD) activities, compared to
CCl4-treated mice. K-3-R and K-3-G also mitigated the CCl4-induced liver histological
alteration, as indicated by histopathological evaluation. These findings demonstrate that
K-3-R and K-3-G have protective effects against acute CCl4-induced oxidative liver damage.
Copyright © 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.  Open access under CC BY-NC-ND license.1. Introduction
The liver is the first organ to metabolize all foreign com-
pounds and hence it is susceptible to injury that can result
in different diseases such as hepatitis, cirrhosis, or hepato-
cellular carcinoma. A major cause of these disorders is
exposure to different environmental pollutants andmacognosy, West China
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ministration, Taiwan. Publchemicals, e.g., paracetamol, carbon tetrachloride (CCl4),
thioacetamide, alcohol, etc. [1]. CCl4 is a xenobiotic that
produces hepatotoxicity in humans, as well as in various
experimental animals [2]. It has been well established that
CCl4 accumulates in hepatic parenchyma cells and is
metabolically activated by cytochrome P450-dependent
monooxygenases to form highly reactive radicals, mainly
the trichloromethyl radical (CCl3*). These radicals bindSchool of Pharmacy, Sichuan University, No. 17 of Renmin Road
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secretion, and react with free oxygen to form CCl3O2* radi-
cals, thereby resulting in protein and DNA damage and lipid
peroxidation [3]. Oxidative stresses play a central role in the
pathology and progression of liver toxicity. Conventional
drugs used in pharmacotherapy, such as steroids, vaccines,
and antiviral drugs, have shown limited therapeutic benefits
and are associated with serious risks of toxicity, especially if
administered chronically or subchronically [4]. As an alter-
native, herbal medicines and their active compounds have
attracted great attention as potential functional ingredients
to protect liver injuries, due to their mild actions and fewer
adverse effects.
Safflower (Carthamus tinctorius L.), a flowering annual
plant of the family Asteraceae widely grown in the world,
has been traditionally used, especially in oriental countries,
to prepare herbal medicines, food colorings, cosmetics, and
even for dyeing fabrics and in paintings [5]. As a traditional
Chinese medicine, safflower has been used in
combination with Salvia and Chuanxiong to soothe the liver
and relieve jaundice for the treatment of old and new liver
disorders [6]. Further studies revealed that the plant
possessed powerful antioxidant and hepatoprotective ef-
fects against CCl4-induced liver injury [7e9], but research
has tended to focus on its mixed extracts and Hydroxysaf-
flor yellow A.
Kaempferol, the most common flavonol present in
different glycosidic forms in several plants including C. tinc-
torius L., has been chosen together with Hydroxysafflor yel-
low A as the phytochemical marker and legal standard
component for controlling the quality of safflower in Chinese
Pharmacopoeia 2010 [10] in China. In our study, two
kaempferol glycosides were isolated from safflower flowers:
kaempferol 3-O-rutinoside (K-3-R) and kaempferol 3-O-
glucoside (K-3-G). Previous studies have shown that K-3-R
isolated from safflower had protective effects against cere-
bral ischemic damage and multi-infarct dementia [11,12]. In
addition, it was reported that K-3-G possessed hep-
atoprotective activity on tacrine-induced cytotoxicity in
human liver-derived HepG2 cells [13]. However, to our best
knowledge, no in vivo studies regarding the hepatoprotective
activity of these two single compounds (K-3-R and K-3-G)
have been conducted. Considering the fact that flavonoids
have significant antioxidant activity [14], and that one of the
main constituents of the species are kaempferol glycosides,
the present study was focused on investigating the functional
roles of K-3-R and K-3-G from safflower against CCl4-induced
oxidative hepatic injury and providing evidence for the pos-
sibility of using K-3-R and K-3-G as a source of natural drugs
for the treatment of liver disorders.2. Materials and methods
2.1. Plant material
Flowers of safflower (C. tinctorius L.) were harvested at Jia-
nyang County (104.64E, 30.43N), Sichuan Province of China
in June 2011 and supplied by Sichuan Academy of Agricultural
Science, Jianyang, China. The reference specimens weredeposited at the Department of Pharmacognosy, West China
School of Pharmacy, Sichuan University, Chengdu, China.
2.2. Extraction and isolation
Air dried and grounded flowers of safflower (2000 g) were
extracted with 75% Ethanol (EtOH) (v/v) at room temperature.
After evaporating EtOH under reduced pressure (< 40oC), the
residue was dissolved in H2O and then subjected to a D101
macroporous resin column previously equilibrated with
water. After the column had been rinsedwith H2O (discarded),
fractions were collected by increasing the EtOH content of the
eluent (20~80%, v/v, successively). The dried residue of 50%
EtOH-eluted fraction was dissolved in H2O and applied to a
polyamide column eluting with 10~80% EtOH. Collected frac-
tions were combined based on their Thin Layer Chromatog-
raphy (TLC) profiles and were concentrated at reduced
pressure. After EtOH evaporation of the 10% EtOH-eluted
fraction, a precipitate developed consisting mainly of K-3-R.
Impurities were removed by recrystallization of the precipi-
tate with EtOH, and 3.5 g of the pure K-3-R was obtained. The
50% EtOH-eluted fraction was further purified on a Sephadex
LH-20 (Pharmacia Biotech, Uppsala, Sweden) column using
50%Methanol (MeOH) as themobile phase to yield 2.4 g of K-3-
G. The structures of the isolated compounds were elucidated
by spectroscopic [mass spectrometry (MS) and 1H-nuclear
magnetic resonance (1H-NMR)] data by comparison with
published data [15,16] (Fig. 1).
K-3-R: ESI-MS m/z: 595.42 [M þ H]. 1H-NMR (CD3OD,
600 MHz): d: 8.06 (2H, d，J ¼ 9.6 Hz, H-20, 60), 6.89 (2H, d,
J ¼ 9.6 Hz, H-30, 50), 6.41 (1H, d, J ¼ 1.8 Hz, H-6), 6.21 (1H, d,
J ¼ 1.8 Hz, H-8), 5.13 (1H, d, J ¼ 7.2 Hz, glucose H-10), 4.51(1H, d,
J ¼ 1.2 Hz, rhamnose H-100), and 1.11 (3H, d, J ¼ 6.0 Hz, rham-
nose 5 CH3). 13C-NMR (CD3OD, 150MHz): d: 16.5 (C-5000), 76.8(C-
100)，75.8(C-200)，74.3(C-300)，72.5(C-400)，70.9(C-600)，70.7(C-
1000)，70.0(C-2000)，68.3(C-3000)，and 67.1(C-4000).
K-3-G: ESI-MS m/z: 449.22 [M þ H]. 1H-NMR (DMSO-d6,
600 MHz): d: 12.62 (br. s, 1H, C5-OH), 10.30 (br. s，1H, C7-OH),
8.06 (2H, d，J ¼ 9.6 Hz, H-20, 60), 6.89 (2H, d, J ¼ 9.6 Hz, H-30, 50),
6.43 (1H, d, J¼ 1.2 Hz, H-6), 6.20 (1H, d, J¼ 1.2 Hz, H-8), and 5.46
(1H, d, J ¼ 7.2, glucose H-10).
2.3. Animals and treatments
Male Kunming mice (20e25 g) were obtained from the Exper-
imental Animal Center of Sichuan University. The animals
were housed at 25 ± 2oC under a 12 hour light/12 hour dark
cycle with access to food and water ad libitum. All the animal
experimental procedures are approved by the Animal Care
and Use Committee of Sichuan University for Nationalities.
The CCl4-induced oxidative toxicity test was performed
according to the previous study with some modifications [17].
After acclimation for 1 week, the animals were randomly
divided into seven groups (n ¼ 8). Group I (normal control) and
Group II (CCl4 model) were given distilled water (10 mL/kg
b.w.). Groups III and IV were administrated K-3-R (200 mg/kg
and 400mg/kg, b.w.). Groups V andVIwere administrated K-3-
G (200 mg/kg and 400 mg/kg, b.w.). Group VII was adminis-
trated biphenyldicarboxylate pills (BP, 100 mg/kg, b.w.). After
the oral administration for 7 days, all mice except those in the
Fig. 1 e Chemical structure of kaempferol 3-O-rutinoside and kaempferol 3-O-glucoside.
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mixture (1:100, intraperitoneally, 10 mL/kg b.w.) 2 hours after
the last administration, while the control group received
peanut oil alone. Then, all of the animals were fasted for 18
hours and sacrificed by cervical dislocation. Blood was
collected, allowed to clot, and serum was separated for
assessment of enzyme activity. Livers were dissected out
immediately, and a portion was transferred into 10% formalin
for histopathological investigation; the rest was properly
stored at 80oC for pending tests.2.4. Measurement of serum total protein, aspartate
aminotransferase, and alkaline phosphatase levels
Collected blood samples were placed at 4oC for 2 hours and
centrifuged at 2000 rpm for 10 minutes at 4

C to obtain the
serum. The level of serum total protein (TP), aspartate
aminotransferase (AST), and alkaline phosphatase (ALP) ac-
tivities were detected using commercial reagent kits obtained
from the Institute of Biological Engineering of Nanjing Jian-
cheng (Nanjing, China) according to the instruction manuals.2.5. Measurement of hepatic malondialdehyde,
glutathione, superoxide dismutase, and catalase levels
Liver homogenates (10.0%, w/v) were prepared with 50mM
cold potassium phosphate buffer (pH 7.4). The resulting sus-
pension was centrifuged at 2000 rpm for 10 minutes, and the
supernatants were collected for further analysis. All treat-
ments were done at 4

C. Protein concentration and malon-
dialdehyde (MDA), glutathione (GSH), superoxide dismutase
(SOD), and catalase (CAT) levels were assayed using com-
mercial reagent kits obtained from the Institute of Biological
Engineering of Nanjing Jiancheng according to the instruction
manuals.2.6. Histopathological examination
Livers slices were fixed with 10% formalin in phosphate
buffered saline for 24 hours and embedded in paraffin. Sec-
tions of 5 mm in thickness were cut, deparaffinized, dehy-
drated, and stained with hematoxylin-eosin (H&E) and
studied under a microscope to observe histopathologicalchanges in the liver. Photographs of each of the slides were
taken at 100magnification.
2.7. Statistical analysis
The data obtained were analyzed using SPSS version 19 (SPSS
Inc., Chicago, IL, USA) and expressed as the mean ± standard
deviation. The data were statistically analyzed by the one way
analysis of variance test andp<0.05wasconsideredsignificant.3. Results
3.1. Effects of K-3-R and K-3-G on serum biochemical
marker levels
As shown in Fig. 2, enzymatic activities of serum AST and ALP
in the normalmice were 31.18 U/L and 12.52 IU/L, respectively.
After administration of CCl4, the levels of these biochemical
markers in mice were markedly increased compared to the
normal control group (p < 0.01). Treatment with K-3-R and K-
3-G showed dose-dependent inhibition in this elevation of
AST and ALP in comparison with the CCl4 model group
(p < 0.01, p < 0.05), while BP treatment only significantly
decreased the enzymatic activity of serum ALP (p < 0.05). The
CCl4 model group had considerably lower TP levels than the
normal group (p< 0.01); K-3-R and K-3-G treatments at 400mg/
kg resulted in a significant improvement in TP level (p < 0.05).
However, low dose K-3-R, K-3-G, and BP treatments did not
observably affect the TP level, although there was a slight
increase. Hence, treatments with K-3-R and K-3-G (400 mg/kg)
had significant protective effects against the acute hepato-
toxicity induced by CCl4 in mice that were superior to the
standard BP (100 mg/kg).
3.2. Effects of K-3-R and K-3-G on CCl4-induced
oxidative stress
Fig. 3 depicts the effects of K-3-R and K-3-G on CCl4-induced
oxidative stress. The level of MDA in the CCl4 model group was
significantly elevated from 0.90 ± 0.14 nmol/mg protein of
normal mice to 1.36 ± 0.33 nmol/mg protein (p < 0.01). Treat-
mentwithK-3-RandK-3-Gconsiderably loweredthe levelof the
CCl4-elevated MDA (p < 0.05, 0.01). Intraperitoneal injection of
Fig. 2 e Effects of kaempferol 3-O-rutinoside (K-3-R) and kaempferol 3-O-glucoside (K-3-G) on (A) serum total protein (TP)
level, (B) alkaline phosphatase (ALP) activity, and (C) aspartate aminotransferase (AST) activity. Data are expressed as
mean ± SD (n ¼ 6). ##p < 0.01, #p < 0.05, statistically significant relative to the normal control group. **p < 0.01, *p < 0.05,
statistically significant relative to the carbon tetrachloride (CCl4) model group.
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Fig. 3 e Effects of kaempferol 3-O-rutinoside (K-3-R) and kaempferol 3-O-glucoside (K-3-G) on (A) hepatic malondialdehyde
(MDA) content, (B) glutathione (GSH) content, (C) superoxide dismutase (SOD) activity, and (D) catalase (CAT) activity. Data
are presented as mean ± SD (n ¼ 7). ##p < 0.01, #p < 0.05, statistically significant relative to the normal control group.
**p < 0.01, *p < 0.05 statistically significant relative to the carbon tetrachloride (CCl4) model group.
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whencomparedwith thenormal group (p< 0.01). This decrease
was significantly reversed through K-3-R and K-3-G treatments
(p < 0.05, 0.01), especially when the dosage was increased to
400 mg/kg; there were no significant differences compared to
thenormal group inGSH level (p<0.05). In contrastwithnormal
mice, the activities of the two hepatic antioxidant enzymes,
SODandCAT,weredecreasedsignificantly inmice treatedwith
CCl4 alone (p< 0.01).However, administrationof bothK-3-Rand
K-3-Gremarkablyavoided thesedecreases inadose-dependent
manner (p < 0.05, 0.01), except for SOD inmice given 200mg/kg
K-3-R (p > 0.05). Treatment with BP at 100 mg/kg increased the
levels of SOD and CAT activities and decreased MDA content
significantly (p < 0.01).3.3. Histological analyses
To assess histological changes, H&E staining of liver tissue
sections from each group was examined. When compared
with the normal group, liver tissue in the CCl4 model group
revealed the most severe damage of all the groups; the liver
sections showed hydropic degeneration, fatty changes, a mild
degree of cellular infiltration, and widespread hepatocellular
necrosis (Fig. 4B). The groups treatedwith K-3-R (Fig. 4C and D)and K-3-G (Fig. 4E and F) exhibited amore or less improvement
in the liver histopathology against CCl4-induced histological
alteration, supporting the results obtained from serum and
hepatic biochemical markers.4. Discussion
CCl4 intoxication is a commonly used and best characterized
animal model of liver injury, since the pathological lesions
developed in CCl4-treated animals closely resemble the
symptoms of cirrhosis in human [18]. Once the liver is
exposed to CCl4, AST which is normally localized to the
cytoplasm is released into the circulation, and causes the level
of these serum marker enzymes to increase significantly.
Membrane disintegration of hepatocytes with subsequent
release of marker enzymes of hepatotoxicity was the result of
CCl4-induced lipid peroxidation. Loss of cell viability is most
often measured as loss of membrane integrity [19]. In addi-
tion, ALP is excreted normally in bile. Hepatic injury induced
by CCl4 could result in defective excretion of bile by hepato-
cytes and so ALP levels could reflect a pathological alteration
in biliary flow [20]. Treatments with both K-3-R and K-3-G
significantly prevented CCl4-induced elevation of AST and
Fig. 4 e Effects of kaempferol 3-O-rutinoside (K-3-R) and kaempferol 3-O-glucoside (K-3-G) on liver histopathology of mice
using hematoxylin-eosin (H&E) staining (original magnification of 100£). (A) Normal control group; (B) carbon tetrachloride
(CCl4) model group; (C) K-3-R (400 mg/kg) þ CCl4 group; (D) K-3-R (200 mg/kg) þ CCl4 group; (E) K-3-G (400 mg/kg) þ CCl4
group; (F) K-3-G (200 mg/kg) þ CCl4 group; and (G) biphenyldicarboxylate (BP) (100 mg/kg) þ CCl4 group. CI ¼ cellular
infiltration; FC ¼ fatty changes; HD ¼ hydropic degeneration; N ¼ hepatocellular necrosis.
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crease stabilization of the plasma membrane and ameliorate
biliary dysfunction effectively, thereby repairing hepatic tis-
sue damage caused by CCl4. In the present study, TP level in
the serum was also measured. Albumin and globulin are the
main components of TP in the plasma and serum albumin is
mainly synthesized by the liver. In drug-induced hepatotox-
icity, albumin synthesis will be depleted due to cirrhosis and
this will lead to a reduction in TP [21]. CCl4 expectedly reduced
serum TP, while treatment with K-3-R and K-3-G restored the
protein content well, especially at a high dose of 400 mg/kg,
which may reflect liver disease, nutritional state, proteins
synthesis state, and others.
Lipid peroxide is a primary parameter which can be
considered as a marker of oxidative injury, and hepatic MDA
formation is commonly used as an indicator of liver tissue
damage involving a series of chain reactions [22]. An increase
in MDA levels in the liver suggested the enhancement of
oxidative stress leading to tissue damage and failure of the
antioxidant defense mechanisms to prevent the formation of
excessive free radicals [23]. In the present study, the elevated
hepatic MDA levels were significantly decreased by adminis-
tration of K-3-R and K-3-G. Therefore, these results provided
evidence which implied that K-3-R and K-3-G could provide
protective effects against CCl4-induced liver damage in terms
of preventing lipid peroxide formation and blocking oxidative
chain reactions.
In order to resist the oxidative stress, the defense systems
in the body possess a host of antioxidant systems, including
the nonenzymatic system (such as GSH) and a series of anti-
oxidant enzymes (such as SOD, CAT) whichwork in concert to
control the cascades of uncontrolled oxidation and protect
cells from oxidative damage by scavenging of overproduced
reactive oxygen species (ROS) [24]. As a nonenzymatic anti-
oxidant, GSH is an important regulator of intracellular redox
homeostasis, which can reduce H2O2, hydroperoxides (ROOH),
and xenobiotic toxicity. As enzymatic antioxidant systems,
SOD and CAT constitute a mutually supportive defense
against ROS to maintain cellular redox balance [25,26]. SOD
can catalyze the dismutation of superoxide anions into
hydrogen peroxide (H2O2) [27]. CAT can further catalyze the
decomposition of H2O2 to H2O and O2 [28]. In our study, we
observed that the levels of GSH, SOD, and CAT were signifi-
cantly lower in CCl4-induced liver injury mice as compared
with those of normal mice, representing severe oxidative
stress status to hepatic cells. Treatment with K-3-R and K-3-G
significantly restored GSH levels as well as SOD and CAT ac-
tivities, suggesting that K-3-R and K-3-G have considerable
antioxidant activities and suppressed CCl4-induced oxidative
liver injury.
Finally, the hepatoprotective effects of K-3-R and K-3-G
were confirmed by histological observations. When
compared to the CCl4 model group, hepatocytes were found to
be normalized, with minimum cellular necrosis, fatty
changes, and cellular infiltration with 400 mg/kg of K-3-R and
K-3-G treatments, thus suggesting that K-3-R and K-3-G were
able to alleviate liver toxicity produced by CCl4 in mice.
In conclusion, the present study demonstrated the strong
hepatoprotective effects of K-3-R and K-3-G, two kaempferol
glycosides isolated from safflower flowers, in a CCl4-inducedliver damage model, probably mediated via the reduction of
oxidative stress and apoptotic cell death. These findings
support the uses of this plant in ethnomedicine and suggest
that K-3-R and K-3-G may be useful as natural sources to
protect liver from oxidative damage.Conflicts of interest
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